共 46 条
- [1] Wolfe F.(1986)A multicentre study of hospitalization in rheumatoid arthritis: frequency, medical-surgical admissions, and charges Arthritis Rheum 29 614-9
- [2] Kleinheksel S.M.(1989)Incidence of gastropathy in destructive arthropathies Scand J Rheumatol Suppl 78 1-4
- [3] Spitz P.W.(1998)Epidemiology of nonsteroidal anti-inflammatory drug-associated gastroduodenal injury Am J Med 104 23S-9S
- [4] Hazleman B.L.(1994)Non-steroidal anti-inflammatory drugs and the gastrointestinal tract Gastroenterologist 2 207-23
- [5] Griffin M.R.(1990)Non-steroidal anti-inflammatory drugs and peptic ulcers BMJ 300 278-84
- [6] Hirschowitz B.I.(1992)NSAID-associated gastroduodenal damage J Pharm Med 2 277-84
- [7] Hawkey C.J.(1998)Recent considerations in nonsteroidal anti-inflammatory drug gastropathy Am J Med 105 31S-8S
- [8] Myerson R.M.(2000)VIGOR Study Group. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis N Engl J Med 343 1520-8
- [9] Singh G.(2000)Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS Study: a randomized controlled trial JAMA 284 1247-55
- [10] Bombardier C.(2005)Pfizer is asked to suspend sales of painkiller [news item] BMJ 330 862-1000